NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients
On Aug. 4, 2020, the National Institutes of Health (NIH) announced that patients admitted with COVID-19 at select…
-
-
HKUMed researchers first discovered SARS-CoV-2 infects human neural progenitor cells and brain organoids
On Aug. 4, 2020, researchers at The University of Hong Kong (HKUMed) collaborated with researchers at the Institute…
-
Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they will be working together with Abiogenesis to initiate…
-
Innovation Pharma and US Regional Biocontainment Laboratory updated brilacidin anti-SARS-CoV-2 in vitro testing
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
-
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
-
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
-
Members of the COVID R&D alliance and quantum leap healthcare collaborative enrolled first patients in I-SPY COVID trial
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
-
La Jolla Institute for Immunology received $1 million from GHR Foundation in support of COVID-19 research
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
-
Lilly initiated phase 3 trial of LY-CoV555 for prevention of COVID-19 at Long-term care facilities in partnership with NIAID
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
-
Bio-Techne and Kantaro Biosciences to launch a quantitative research use only COVID-19 serology test
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
-
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
-
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
-
Serum Institute of India received approval to start human trials for Oxford vaccine
On Aug. 1, 2020, the Serum Institute of India (SII) got the approval to start human trials in…
-
Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deployment
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the National Institutes of Health (NIH) announced that it had invested $248.7 million in…
-
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the National Institutes of Health (NIH) to support…
-
Sanofi and GSK announced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
-
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
-
Researchers reported fat-based molecules key to Zika virus infection
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
-
OraSure’s OMNIgene-ORAL device included in EUA granted to Clinical Reference Laboratory for self-collected SARS saliva test
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
-
NIH researchers discovered new set of channels connecting malaria parasite and blood cells
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
Tyson Foods launched nationwide COVID monitoring strategy and expanded health staff
On Jul. 30, 2020, Tyson Foods announced that it had launched a new, industry-leading monitoring program and expanding…
-
BD announced $24 million US Government investment to support scale up of US manufacturing of COVID-19 diagnosic tests
On Jul. 30, 2020, BD (Becton, Dickinson) announced a $24 million investment from the U.S. Department of Defense…
-
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrated robust protection in pre-clinical studies
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
-
Seqirus began shipping 2020/21 influenza vaccines to U.S. market
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
-
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
-
Sanofi and GSK agreed with the UK government to supply up to 60 million doses of COVID-19 vaccine
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
-
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
